secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001493152-23-046601
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences raises $1.8M via warrant exercise inducement at $1.37/share
-------------------------------------------------------------------------------

- Gross proceeds ~$1.8M from exercise of 1,122,000 existing warrants at reduced price of $1.37/share.
- Issued new warrants to purchase up to 2,244,000 shares at $1.37, exercisable for 5 years.
- Paid $0.125 cash inducement per new warrant share upon exercise of existing warrants.
- Roth Capital acted as financial advisor; advisory fees ~$108,000.
- Company to file resale registration statement for new warrant shares by Jan 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315223046601/0001493152-23-046601-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315223046601/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-046601

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer